Company profile: Gyros Protein Technologies
1.1 - Company Overview
Company description
- Provider of peptide synthesizers, reagents, and bioanalysis platforms for universities, biotechnology and pharmaceutical companies, and peptide houses. Offers automated peptide synthesis systems for discovery to pre-clinical studies, Gyrolab systems for high-throughput immunoassays for impurity analysis and titer quantification, PurePep EasyClean kits for catch-and-release peptide purification, and IQ/OQ services for compliant installation and operation.
Products and services
- Protein Technologies Peptide Synthesizers: Industrial-grade automated systems for peptide synthesis, engineered to meet various research needs from discovery to pre-clinical studies across academic, biotechnology, pharmaceutical, and peptide house applications
- PurePep EasyClean Purification Kits: Modular kits for peptide purification, using catch-and-release methodologies to ensure efficient purification and facilitate peptide modification for research and pre-clinical workflows
- Gyrolab Systems: High-throughput bioanalysis platforms offering immunoassays for impurity analysis and titer quantification in university, biotechnology, and pharmaceutical laboratories
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Gyros Protein Technologies
Touchstone Innovations
HQ: United Kingdom
Website
- Description: Provider of company creation, building and investment for early-stage and pioneering technology companies and licensing opportunities developed from outstanding scientific research, focusing on the Golden Triangle of London, Cambridge and Oxford, via a robust, fully integrated business model that begins with the original idea.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Touchstone Innovations company profile →
Sloning Biotechnology
HQ: Germany
Website
- Description: Provider of tailored protein engineering solutions for industrial and biopharmaceutical sectors, leveraging the patented Slonomics technology platform to build DNA molecules with exceptional features regarding sequence limitations, reliability, and production cost on an industrial-scale robotic system.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sloning Biotechnology company profile →
Complete Genomics
HQ: United States
Website
- Description: Provider of DNA sequencing platforms for human genome sequencing and analysis, supporting commercial-scale research into genetic mechanisms underlying drug responses and complex diseases. Offerings include DNBSEQ-T7 and DNBSEQ-T20x2 ultra-high throughput sequencers, DNBSEQ-G400 high throughput, DNBSEQ-G99 fast mid throughput, DNBSEQ-E25 portable, and CoolMPS for genomic analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Complete Genomics company profile →
Astero Bio
HQ: United States
Website
- Description: Provider of medical equipment and supplies manufacturing, based in Menlo Park, CA, United States.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Astero Bio company profile →
Mobilion Systems
HQ: United States
Website
- Description: Provider of high-resolution ion mobility mass spectrometry and targeted molecular analyses to identify and analyze challenging molecules that other instruments so far have failed to detect. Offers MOBIE for rapid, high-resolution separation and identification, plus targeted lipidomics, targeted proteomics, glycomics, metabolomics, and therapeutic oligonucleotide analysis for disease research, diagnostics, biomarker discovery, and therapeutic development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mobilion Systems company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Gyros Protein Technologies
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Gyros Protein Technologies
2.2 - Growth funds investing in similar companies to Gyros Protein Technologies
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Gyros Protein Technologies
4.2 - Public trading comparable groups for Gyros Protein Technologies
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →